Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05010772 |
|---|---|
| Brief Title: | Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission |
| First Submitted : | August 11, 2021 |
| First Submitted that Met QC Criteria : | August 11, 2021 |
| First Posted : | August 18, 2021 |
| Last Update Submitted that Met QC Criteria : | February 23, 2024 |
| Last Update Posted : | February 26, 2024 |